Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cogent Biosciences (COGT) Accumulated Depreciation & Amortization (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of Accumulated Depreciation & Amortization data on record, last reported at $412000.0 in Q4 2020.

  • For Q4 2020, Accumulated Depreciation & Amortization fell 91.1% year-over-year to $412000.0; the TTM value through Dec 2020 reached $412000.0, down 91.1%, while the annual FY2020 figure was $412000.0, 91.1% down from the prior year.
  • Accumulated Depreciation & Amortization reached $412000.0 in Q4 2020 per COGT's latest filing, down from $4.6 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $4.6 million in Q4 2019 and bottomed at $412000.0 in Q4 2020.
  • Average Accumulated Depreciation & Amortization over 3 years is $2.8 million, with a median of $3.5 million recorded in 2018.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 32.47% in 2019, then tumbled 91.1% in 2020.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $3.5 million in 2018, then skyrocketed by 32.47% to $4.6 million in 2019, then crashed by 91.1% to $412000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $412000.0 in Q4 2020, $4.6 million in Q4 2019, and $3.5 million in Q4 2018.